{"transactions":[{"id":2312052,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-04-01T20:27:10.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":700,"price":44.55,"value":31185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":14518,"source":{"system":"sec-edgar","filing":"0001225208-22-005306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822005306/doc4.xml","form_type":"4"}},{"id":2362890,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Deferred Stock Units","published_at":"2022-03-02T21:29:28.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":1426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":1426},"source":{"system":"sec-edgar","filing":"0001225208-22-003866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003866/doc4.xml","form_type":"4"}},{"id":2362889,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-03-02T21:29:28.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":766,"price":44.17,"value":33834.22,"ownership":{"direct":true},"balance_after":15218,"source":{"system":"sec-edgar","filing":"0001225208-22-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003866/doc4.xml","form_type":"4"}},{"id":2362888,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-03-02T21:29:28.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":1426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":15984,"source":{"system":"sec-edgar","filing":"0001225208-22-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003866/doc4.xml","form_type":"4"}},{"id":2376161,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Performance Share Units","published_at":"2022-02-24T21:21:51.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":7411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023."}],"balance_after":7411,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":7411},"source":{"system":"sec-edgar","filing":"0001225208-22-003298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003298/doc4.xml","form_type":"4"}},{"id":2380098,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Deferred Stock Units","published_at":"2022-02-23T21:18:18.000Z","date":"2022-02-21","kind":"exercise","acquired":false,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":1091,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":1090},"source":{"system":"sec-edgar","filing":"0001225208-22-003086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003086/doc4.xml","form_type":"4"}},{"id":2380097,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-23T21:18:18.000Z","date":"2022-02-21","kind":"tax_withholding","acquired":false,"shares":606,"price":42.55,"value":25785.3,"ownership":{"direct":true},"balance_after":14558,"source":{"system":"sec-edgar","filing":"0001225208-22-003086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003086/doc4.xml","form_type":"4"}},{"id":2380096,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-23T21:18:18.000Z","date":"2022-02-21","kind":"exercise","acquired":true,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":15164,"source":{"system":"sec-edgar","filing":"0001225208-22-003086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003086/doc4.xml","form_type":"4"}},{"id":2383559,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Deferred Stock Units","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":2076,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2383558,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Restricted Stock Units","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-17","kind":"exercise","acquired":false,"shares":1416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":4250,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":1416},"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2383557,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":510,"price":42.55,"value":21700.5,"ownership":{"direct":true},"balance_after":14074,"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2383556,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":14584,"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2383555,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":713,"price":42.83,"value":30537.79,"ownership":{"direct":true},"balance_after":13547,"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2383554,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:28.000Z","date":"2022-02-17","kind":"exercise","acquired":true,"shares":1416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":14260,"source":{"system":"sec-edgar","filing":"0001225208-22-002925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002925/doc4.xml","form_type":"4"}},{"id":2389899,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T01:31:11.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":15367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":15367,"derivative":{"exercise_price":44.19,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":15367},"source":{"system":"sec-edgar","filing":"0001225208-22-002683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002683/doc4.xml","form_type":"4"}},{"id":2389898,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Restricted Stock Units","published_at":"2022-02-18T01:31:11.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":5374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":5374,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":5374},"source":{"system":"sec-edgar","filing":"0001225208-22-002683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002683/doc4.xml","form_type":"4"}},{"id":2389897,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Deferred Stock Units","published_at":"2022-02-18T01:31:11.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":1292,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":1292},"source":{"system":"sec-edgar","filing":"0001225208-22-002683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002683/doc4.xml","form_type":"4"}},{"id":2389896,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-18T01:31:11.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":707,"price":44.01,"value":31115.07,"ownership":{"direct":true},"balance_after":12844,"source":{"system":"sec-edgar","filing":"0001225208-22-002683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002683/doc4.xml","form_type":"4"}},{"id":2389895,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-02-18T01:31:11.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":13551,"source":{"system":"sec-edgar","filing":"0001225208-22-002683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002683/doc4.xml","form_type":"4"}},{"id":2451894,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, CRM, Diagnostics"}}],"security":"Common Stock","published_at":"2022-01-04T21:33:41.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":700,"price":42.59,"value":29813.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":12062,"source":{"system":"sec-edgar","filing":"0001225208-22-000212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822000212/doc4.xml","form_type":"4"}},{"id":2553136,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-10-04T21:21:34.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":700,"price":43.49,"value":30443.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":12762,"source":{"system":"sec-edgar","filing":"0001225208-21-012786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821012786/doc4.xml","form_type":"4"}},{"id":2642494,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2021-07-06T20:10:57.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant."}],"balance_after":5315,"derivative":{"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001225208-21-010277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010277/doc4.xml","form_type":"4"}},{"id":2642493,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-07-06T20:10:57.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":874,"price":43.36,"value":37896.64,"ownership":{"direct":true},"balance_after":13041,"source":{"system":"sec-edgar","filing":"0001225208-21-010277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010277/doc4.xml","form_type":"4"}},{"id":2642492,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-07-06T20:10:57.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":700,"price":42.78,"value":29946.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":13915,"source":{"system":"sec-edgar","filing":"0001225208-21-010277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010277/doc4.xml","form_type":"4"}},{"id":2642491,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-07-06T20:10:57.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":14615,"source":{"system":"sec-edgar","filing":"0001225208-21-010277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010277/doc4.xml","form_type":"4"}},{"id":2762607,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-04-02T20:13:11.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":700,"price":38.61,"value":27027.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":12844,"source":{"system":"sec-edgar","filing":"0001225208-21-006326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821006326/doc4.xml","form_type":"4"}},{"id":2822980,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2021-03-02T21:16:40.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":1426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":1426,"derivative":{"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":1426},"source":{"system":"sec-edgar","filing":"0001225208-21-004225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821004225/doc4.xml","form_type":"4"}},{"id":2822979,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-03-02T21:16:40.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":704,"price":38.78,"value":27301.12,"ownership":{"direct":true},"balance_after":13544,"source":{"system":"sec-edgar","filing":"0001225208-21-004225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821004225/doc4.xml","form_type":"4"}},{"id":2822978,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-03-02T21:16:40.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":1426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":14248,"source":{"system":"sec-edgar","filing":"0001225208-21-004225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821004225/doc4.xml","form_type":"4"}},{"id":2841173,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2021-02-23T22:14:57.000Z","date":"2021-02-21","kind":"exercise","acquired":false,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":2181,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":1090},"source":{"system":"sec-edgar","filing":"0001225208-21-003525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003525/doc4.xml","form_type":"4"}},{"id":2841172,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-23T22:14:57.000Z","date":"2021-02-21","kind":"tax_withholding","acquired":false,"shares":529,"price":38.03,"value":20117.87,"ownership":{"direct":true},"balance_after":12822,"source":{"system":"sec-edgar","filing":"0001225208-21-003525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003525/doc4.xml","form_type":"4"}},{"id":2841171,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-23T22:14:57.000Z","date":"2021-02-21","kind":"exercise","acquired":true,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":13351,"source":{"system":"sec-edgar","filing":"0001225208-21-003525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003525/doc4.xml","form_type":"4"}},{"id":2847410,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2021-02-19T21:24:46.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":3113,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0001225208-21-003180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003180/doc4.xml","form_type":"4"}},{"id":2847409,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:24:46.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":18224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":18224,"derivative":{"exercise_price":37.5,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":18224},"source":{"system":"sec-edgar","filing":"0001225208-21-003180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003180/doc4.xml","form_type":"4"}},{"id":2847408,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Restricted Stock Units","published_at":"2021-02-19T21:24:46.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":5666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":5666,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":5666},"source":{"system":"sec-edgar","filing":"0001225208-21-003180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003180/doc4.xml","form_type":"4"}},{"id":2847407,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-19T21:24:46.000Z","date":"2021-02-18","kind":"tax_withholding","acquired":false,"shares":542,"price":37.52,"value":20335.84,"ownership":{"direct":true},"balance_after":12261,"source":{"system":"sec-edgar","filing":"0001225208-21-003180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003180/doc4.xml","form_type":"4"}},{"id":2847406,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-19T21:24:46.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":12803,"source":{"system":"sec-edgar","filing":"0001225208-21-003180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821003180/doc4.xml","form_type":"4"}},{"id":2856238,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2021-02-17T21:16:04.000Z","date":"2021-02-15","kind":"exercise","acquired":false,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":2584,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":1292},"source":{"system":"sec-edgar","filing":"0001225208-21-002707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821002707/doc4.xml","form_type":"4"}},{"id":2856237,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-17T21:16:04.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":707,"price":38.39,"value":27141.73,"ownership":{"direct":true},"balance_after":11766,"source":{"system":"sec-edgar","filing":"0001225208-21-002707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821002707/doc4.xml","form_type":"4"}},{"id":2856236,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-02-17T21:16:04.000Z","date":"2021-02-15","kind":"exercise","acquired":true,"shares":1292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":12473,"source":{"system":"sec-edgar","filing":"0001225208-21-002707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821002707/doc4.xml","form_type":"4"}},{"id":2923260,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2021-01-05T21:20:43.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":700,"price":36.08,"value":25256.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":11181,"source":{"system":"sec-edgar","filing":"0001225208-21-000253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821000253/doc4.xml","form_type":"4"}},{"id":2961774,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Deferred Stock Units","published_at":"2020-12-02T21:12:25.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":1485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":1485},"source":{"system":"sec-edgar","filing":"0001225208-20-014096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820014096/doc4.xml","form_type":"4"}},{"id":2961773,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2020-12-02T21:12:25.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":733,"price":33.65,"value":24665.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":11881,"source":{"system":"sec-edgar","filing":"0001225208-20-014096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820014096/doc4.xml","form_type":"4"}},{"id":2961772,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":128555,"kind":"person","name":"Olson Scott","position":1,"cik":"0001816850","reported_name":"Olson Scott","relationship":{"officer":true,"officer_title":"SVP & Pres, Rhythm Management"}}],"security":"Common Stock","published_at":"2020-12-02T21:12:25.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":1485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":12614,"source":{"system":"sec-edgar","filing":"0001225208-20-014096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520820014096/doc4.xml","form_type":"4"}}]}